The features underlying the recognition of C. albicans epitopes by host receptors are summarized, and a solid foundation for the development of new antifungal agents for the clinical treatment of systemic infections caused by C. albicans is laid.
Abstract
Candida albicans is a commonly encountered dimorphic fungus that normally resides in the human body. Once the host is immune-compromised or endures long-term antibiotic treatment, C. albicans will transform into an opportunistic pathogen that can cause from superficial mucosal diseases (e.g., oropharyngeal candidiasis) to life-threatening invasive infections (e.g., candidemia). Since the resistance rate of clinical C. albicans is rapidly increasing, there is an urgency to expand the current antifungal armamentarium. It has been shown that a growing body of host receptors can recognize the cell wall components of C. albicans (e.g., β-glucan, chitin and mannan), and trigger potent innate immune responses with enhanced phagocytosis, reactive oxygen species, and inflammatory cytokine production. In this review, we classify the host receptors into two categories: the receptors that directly interact with the epitopes of C. albicans, and those that act as co-receptors to aid in epitope recognition. The former receptors include Dectin-1/2/3, Mincle, MR, DC-SIGN, MBL, CR3, LYSMD3, NKp30 and SPINK7, whereas the latter ones consist of TLR2/4, EphA2/B2, galectin-3, gC1qR, AhR, EGFR and HER2. We not only characterize the antifungal modes of these host receptors during C. albicans infection, but also summarize the features underlying the recognition of C. albicans epitopes by these receptors. The advancements in PRRs can largely expand our scientific understanding of antifungal mechanisms, and lay a solid foundation for the development of new antifungal agents for the clinical treatment of systemic infections caused by C. albicans.
Candida spp. are surviving in human biotopes under constant exposure to innate and adaptive immune factors, using the mechanisms which suppress/neutralize the host's antimicrobial defenses. Furthermore, the aggressiveness of Candida spp. is mediated by a number of their pathogenicity factors, especially, those providin...
O. A. Kapustina, T. M. Pashkova, V. A. Gritsenko· Russian Journal of Immunolog...· 0 citations
SUMMARY Candida is a taxonomically fluid genus that includes several opportunistic pathogens, for which the clinical incidence has been increasing for decades. Though Candida now represents a lower proportion of cases than in the past, Candida albicans remains the most prevalent species in human infections, and dissemi...
Pedro Miramón, Hannah B. Wilson, Michael C. Lorenz· Microbiology and Molecular B...· 0 citations
Severe fungal diseases are an increasingly important yet underrecognized cause of global morbidity and mortality, with the greatest impact among immunocompromised individuals and populations with limited access to timely diagnosis and treatment. Disease outcome is determined by a dynamic host–fungus interface in which...
E. Ortíz-Prado, Jorge Vásconez-González, Karla Alejandra Cuenca et al.· Tropical Medicine and Infect...· 0 citations
This review aims to provide a comprehensive overview of the major virulence mechanisms that facilitate this commensal-to-pathogen transition, with particular emphasis on adhesion, morphological switching, biofilm formation, epithelial invasion, and host tissue damage.
A. S, S. S, S. G. et al.· Saudi Journal of Oral and De...· 0 citations
Oral candidiasis (OC), caused mainly by Candida albicans, is a common opportunistic fungal infection and typically affects immunocompromised individuals. The rise in antifungal resistance, biofilm-associated persistence, and immune evasion mechanisms has complicated OC management. This review examines in depth the mole...
B. Sahu, Priyanka Debta, S. Patra et al.· Frontiers in Cellular and In...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.